Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV282
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,185
Award facts
- Contract value 100% obligated
- $29,185.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,185.16 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by January 28, 2026. The award supports the DLA's pharmaceutical supply chain operations, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which does business as AmerisourceBergen and serves as a critical pharmaceutical distributor for federal healthcare systems.
This delivery order is issued under Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. That comprehensive IDC vehicle enables the supply of a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. The current task order for Vyndamax—a medication used in the treatment of transthyretin amyloidosis—exemplifies the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains to support Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FV282?
SPE2DR26FV282 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV282 worth?
The government has obligated $29,185 on SPE2DR26FV282.
Is contract SPE2DR26FV282 an order under another contract?
Yes. SPE2DR26FV282 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV282 competed?
The extent of competition for SPE2DR26FV282 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award